IRPS is linked to an immunosuppressive tumor microenvironment characterized by activating forkhead box P3 (FOXP3+) CD4+ T lymphocytes, which further suppress T-cell functions and promote T-cell exhaustion [97,98]. The gene discussed is FOXP3; the disease is neoplasm.